Susceptibility of Plasmodium falciparum to the drugs used to treat severe malaria (quinine) and to prevent malaria (mefloquine, cycloguanil) in Comoros Union and Madagascar

South African Medical Journal

Volumn 94, Issue 1, 2004, Pages 47-51

  Randrianarivelojosia, Milijaona ^a   Randrianasolo, Laurence ^a   Randremanana, Rindra V ^a   Randriamanantena, Arthur ^a   Ratsimbasoa, Arsène ^a   Rakotoson, Jean Désiré ^b  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b Institut d'Hygiene Sociale Antananarivo   (Madagascar)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CYCLOGUANIL; MEFLOQUINE; QUININE;

ARTICLE; COMOROS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DRUG POTENCY; DRUG SENSITIVITY; DRUG USE; IC 50; IN VITRO STUDY; ISOLATION PROCEDURE; MADAGASCAR; MALARIA; MONITORING; NONHUMAN; PLASMODIUM FALCIPARUM; PRACTICE GUIDELINE; RURAL AREA; URBAN AREA; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIMALARIALS; COMOROS; DRUG RESISTANCE; HUMANS; MADAGASCAR; MALARIA, FALCIPARUM; MEFLOQUINE; PLASMODIUM FALCIPARUM; QUININE; TRIAZINES;

EID: 1142287324     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Wongsrichanalai C, Pickard AL, Wernsdorfer WH, Meshnick SR. Epidemiology of drug resistant malaria. Lancet Infect Dis 2002; 2: 209-218.
2. Arroson B, Bengtsson E, Bjorkman A, Pehrson PO, Rombo L, Walhgren M. Chloroquine resistant falciparum malaria in madagascar and Kenya. Ann Trop Med Parasitol 1981; 75: 367-373.
3. Deloron P, Le Bras J, Ramanamirija JA, Coulanges P. Plasmodium falciparum in Madagascar: in vivo and in vitro sensitivity to seven drugs. Ann Trop Med Parasitol 1985; 79: 357-365.
4. Randrianarivelojosia M, Raharimalala L, Randrianmanantena A, Jambou R. Drug resistance of Plasmodium falciparum in coastal regions of Madagascar. Med Trop 2000; 60: 243-249.
5. Ariey F, Randrianaruvelojosia M, Duchemin JB, et al. Plasmodium falciparum pfcrt K76T mutation mapping: a useful tool for malaria control strategy in Madagascar. J Infect Dis 2002; 185: 710-712.
6. World Health Organization. International Travel and Health. Geneva: WHO, 2002: 193.
7. Department of Health, Republic of South Africa. Guidelines for the Prophylaxis of Malaria. Pretoria: Government Printer, 1996: 1-15. BB7128/50 000.
8. Jeanne I, Randremanana RV, Robert V, et al. Madagascar biography. In: Malaria Research Groups, eds. Madagascar Malaria Map. 1st ed. Antananviro: Institut Pasteur de Magagascar, 2003: 3-10.
9. Warrell DA, Molyneux ME, Beales PE. Severe and complicated malaria. Trans R Soc Trop Med Hgy 1990; 84: Suppl. 2, 1-65.
10. Le Bras J, Deloron P. In vitro study of drug sensibility of Plasmodium falciparum. An evaluation of a new semi-microtest. Am J Trop Med Hyg 1983; 32: 447-451.
11. Basco LK, Le Bras J. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Ann Trop Med Parasitol 1994; 88: 131-136.
12. Parzy D, Doerig C, Pradines B, Rico A, Fusai T, Doury JC. Proguanil resitance in Plasmodium falciparum African isolates: assessment by mutation-specific polymerase chain reaction and in vitro susceptibility testing. Am J Trop Med Hyg 1997; 57: 646-650.
13. Randrianaruvelojosia M, Raharimalala LA, Randrianasolo L, et al. Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro. Ann Trop Med Parasitol 2001; 95: 237-243.
14. Rason MA, Ariey F, Rafidimanantsoa L, Andrianantenaina BH, Sohandra Harisoa JL, Randrianaruvelojosia M. Monitoring the drug-sensitivity of Plasmodium falciparum in coastal towns in Madagascar by use of in vitro chemosensitivity and mutation detection tests. Parasite 2002; 9: 247-253.
15. Randrianaruvelojosia M, Ratsimbasoa A, Randrianasolo L, Randrianarijaona A, Jambou R. In vitro sensitivity of Plasmodium falciparum to chloroquine, halofantrine, mefloquine and quinine in Madagascar. East Afr Med J 2002; 79: 237-241.
16. Jambou R, Raharimalala L, Milijaona R, et al. Etude de la chimiosensibilité de Plasamodium falciparum à Madagascar: 2-Efficacité et tolérance de la quine base 250 mg (Surquina) dans le traitement de l'acceś palustre simple. Arch Inst Pasteur Madagascar 1998; 64: 56-61.
17. Trape JF, Pison G, Spiegel A, Enel C, Rogier C. Combating malaria in Africa. Trends Parasitol 2002; 18: 224-230.
18. Assimadi JK, Gbadoé AD, Agbodjan-Djossou O, et al. Intravenous quinine treatment of cerebral malaria in African childeren: comparison of a loading dose regimen to a regimen without loading dose. Arch Pediatr 2002; 9: 587-294.
19. Kofoed PE, Co F, Poulsen A, et al. Treatment of Plasmodium falciparum malaria with quinine in children in Guinea-Bissau: one daily dose is sufficient. Trans R Soc Trop Med Hgt 2002; 96: 185-188.
20. Athan E, Durrheim DN, Barnes K, Mngomezulu NM, Mabuza A, Govere J. Effectiveness of short-course quinine and single-dose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria Mpumalanga Province, South Africa. S Afr Med J 2001; 91: 592-594.
21. World Health Organisation. The Use of Antimalarial Drugs. Report of a WHO Informal Consultation. WHO/CDS/RBM/2001.33: 62-66.
22. Milijaona R, Jambou R, Raharimalala L, Ranaivo L, Rason MA, Roux J. Mefloquine resistant strains of Plasmodium falciparum in Madagascar: impact for travellers and public health. Am Trop Med Parasitol 2000; 94: 313-317.
23. Kublin JG, Dzinjalamala FK, Kamwendo DD, et al. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 2002; 185: 380-388.